Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

The requested reference [215bb7bb16a77aa7ca23ac510a883967765057de] no longer exists in our database. It has been replaced by the current reference: [f571f57e1967080c8a1870d8405d5f940113c580]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of the present study is to assess and compare in healthy non-pregnant women 18 to 40 years of age the safety and immunogenicity of a liquid formulation of Group B Streptococcus (GBS) Trivalent Vaccine (not requiring reconstitution prior to administration), and of the lyophilized formulation of GBS Trivalent Vaccine, administered in non-pregnant and pregnant women in the clinical development program to date.
Epistemonikos ID: b657540dd7850df924625c1032f763bcc44be52e
First added on: May 12, 2024